View Older Stories View More Recent Stories
-
Inventiva Appoints Andrew Obenshain as Chief Executive Officer
-
Russian manufacturing sector sees sharper contraction in September, PMI shows
-
Stocks mixed, gold hits record as US government shuts down
-
UK's Institute of Directors reports record-low business morale
-
Moderate US job openings, weak hiring underscore labor market stagnation
-
AiFi Debuts eddie: First API for the Physical World to Transform Spaces into Intelligent, Responsive Environments
-
US job openings increase moderately in August; hiring declines
-
Imperial Oil layoffs announced Monday account for about half of Exxon's 2,000 job cuts announced today - Spokersperson
-
Exit Strategies Matter: New Research Reveals Why Poorly Managed Layoffs Harm Company Morale, Trust, and Brand Confidence
-
Exxon to cut 2,000 jobs in restructuring hitting Canada and EU
-
Gelt, the First AI-Native Tax Firm, Raises $13M in Series A Funding to Transform Tax Strategy Into Year-Round Wealth Optimization
-
US government faces brain drain as 154,000 federal workers exit this week
-
Wall Street indexes close higher with quarterly and monthly gains even as US government shutdown looms
-
German unemployment rises more than expected in September
-
No Credit Check Loans with Guaranteed Approval: RadCred Launches AI-Powered Bad Credit Loans for Low Credit Score Borrowers in the USA
-
US court suspends Trump layoff of hundreds at Voice of America
-
China's service activity growth moderates, private PMI shows
-
Trump can slash Education Department's civil rights staff, court rules
-
Sutro Biopharma cuts workforce by one-third to extend cash runway
-
Sutro Biopharma Announces Operational Restructuring Intended to Extend Cash Runway through Key Milestones
-
Trump administration begins detailing shutdown plans as deadline nears
-
Atkore reviews strategic alternatives including potential asset sales
-
Atkore Provides Update on Strategic Actions
-
Comcast names insider Michael Cavanagh as co-CEO ahead of cable spinoff
-
Inventiva reports its unaudited 2025 first-half financial results and provides a corporate update
-
Lufthansa to cut 4,000 jobs, raises profitability targets
-
Virtrify Launches Hybrid Hiring Model to Revolutionize U.S. Staffing
-
Toyota workers in Brazil approve temporary layoff plan, union says
-
Jaguar Land Rover shutdown driving suppliers to cut jobs and reduce hours - survey
-
Exclusive-Lufthansa to cut thousands of jobs in pursuit of efficiency
-
European shares recover from three-week lows, but weekly momentum fizzles
-
Canada Post workers go on nationwide strike after government calls for reform
-
Top Wall St regulator says he will review White House call for layoff plans
-
Job market recovery masks fragile no-hire-no-fire reality, Jefferies warns
-
Michael Eisenga, CEO of First American Properties, Addresses Economic Crossroads: How We Got Here, Where We Are, and the Road Ahead
-
Bosch to cut 13,000 jobs to bring down costs in tough autos market
-
Starbucks closing stores, including iconic Seattle roastery, as CEO deepens restructuring
-
Q4 FY25 and Full FY25 Results: LuxExperience Reports Strong FY25 Results for Its Mytheresa Business With Net Sales Growth of +12% in Q4 and +9% for the Full Fiscal Year With Adj. EBITDA Growing +73%
-
Lawmakers seek answers from major US firms over H-1B visa use amid layoffs
-
Denmark's 'Novo Town' holds its breath as Wegovy fever fades
-
US plans to extend Africa trade deal by a year, says Lesotho minister
-
Steelcase Reports Second Quarter Fiscal 2026 Results
-
Fifteen Presidents & CEOs Urge President Trump to Sign the Section 232 Tariffs on Lumber and Foreign Cabinet Imports into Law
-
Ida Byrd-Hill Releases Culture Re-Wired: Unleash Your Inner AI CEO to Reduce Massive Layoff Fear
-
France to review Nissan Europe's supplier payments, letter shows
-
CARBIOS presents its 2025 half-year results and confirms its objective to build a PET biorecycling plant, with a revised timeline.
-
UK Businesses Grappling with Late Payment Crisis – Top Debt Collection Agencies helping fight back
-
US business activity cools further, no widespread price increases
-
Seres Therapeutics cuts workforce 25% as it seeks funding for drug study
-
Seres Therapeutics Announces Further Constructive Feedback from FDA on SER-155 Phase 2 Study Protocol and Implements Cost Reduction Actions to Extend Cash Runway
